BIAL - PORTELA & CA S.A., BIAL - HOLDING, S.A. et al v. Aurobindo Pharma Ltd. et al > Summary
Court Case Number 1:21-cv-01682
Filing Date Nov 29, 2021
Termination Date Nov 14, 2022
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesColm F. Connolly
Plaintiff Attorneys
6Bial
Attorney Name: Steven J. Balick
Ashby & Geddes
Bial
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Sunovion Pharmaceuticals
Attorney Name: Steven J. Balick
Ashby & Geddes
Sunovion Pharmaceuticals
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Sunovion Pharmaceuticals
Attorney Name: Karen Ann Jacobs
Morris Nichols Arsht & Tunnell
Sunovion Pharmaceuticals
Attorney Name: Jennifer O. Ying
Morris Nichols Arsht & Tunnell
Defendant Attorneys
6Aurobindo Pharma
Attorney Name: Michael P. Hogan
Kratz & Barry
Aurobindo Pharma
Attorney Name: Timothy H. Kratz
Kratz & Barry
Aurobindo Pharma
Attorney Name: Touhey Myer
Kratz & Barry
Aurobindo Pharma USA
Attorney Name: Michael P. Hogan
Kratz & Barry
Aurobindo Pharma USA
Attorney Name: Timothy H. Kratz
Kratz & Barry
Aurobindo Pharma USA
Attorney Name: Touhey Myer
Kratz & Barry
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
10912781 | Pharmaceutical composition comprising licarbazepine acetate | Feb 9, 2021 |
10702536 | Methods of treatment of partial onset seizures using eslicarbazepine acetate | Jul 7, 2020 |
10695354 | Methods of treatment of partial onset seizures using eslicarbazepine acetate | Jun 30, 2020 |
10675287 | Methods of treatment of partial onset seizures using eslicarbazepine acetate | Jun 9, 2020 |
09763954 | Therapeutical uses of eslicarbazepine | Sep 19, 2017 |
09750747 | Treatments involving eslicarbazepine acetate or eslicarbazepine | Sep 5, 2017 |
09643929 | Asymmetric catalytic reduction of oxcarbazepine | May 9, 2017 |
09566244 | Pharmaceutical composition comprising licarbazepine acetate | Feb 14, 2017 |
09206135 | Asymmetric catalytic reduction of oxcarbazepine | Dec 8, 2015 |
08372431 | Pharmaceutical composition comprising licarbazepine acetate | Feb 12, 2013 |